Sutro Biopharma prices $110 million stock offering at $13.98 per share Feb 10, 2026 07:06AM
Citizens Upgrades Sutro Biopharma (STRO) to Market Outperform Jan 20, 2026 02:43AM
Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026 Dec 21, 2025 04:00AM
Sutro Biopharma (STRO) Revealed ADC, STRO-227 at Analyst Event Nov 17, 2025 04:42AM
Sutro Biopharma, Inc. (STRO) Misses Q3 EPS by 27c Nov 6, 2025 06:19PM


Sep 29, 2025 05:05PM Sutro Biopharma cuts workforce by one-third to extend cash runway
Aug 15, 2025 06:01AM Citizens JMP Reiterates Market Perform Rating on Sutro Biopharma (STRO)
Aug 7, 2025 04:40PM Sutro Biopharma, Inc. (STRO) Tops Q2 EPS by 27c
Jul 22, 2025 08:02AM Sutro Biopharma partners with FDA on antibody drug conjugate standards
Jun 16, 2025 03:12AM Piper Sandler Upgrades Sutro Biopharma (STRO) to Overweight
Jun 2, 2025 08:00AM Sutro Biopharma Inc. (STRO) Appoints Greg Chow as CFO
May 9, 2025 04:40PM Sutro Biopharma, Inc. (STRO) Misses Q1 EPS by 6c
Mar 17, 2025 08:18AM H.C. Wainwright Downgrades Sutro Biopharma (STRO) to Neutral
Mar 14, 2025 03:22PM Oppenheimer Downgrades Sutro Biopharma (STRO) to Perform
Mar 14, 2025 03:21PM Sutro Biopharma (STRO) PT Lowered to $8 at Jefferies
Mar 14, 2025 10:15AM Truist Securities Reiterates Buy Rating on Sutro Biopharma (STRO), Removes PT
Mar 14, 2025 06:22AM BofA Securities Double Downgrades Sutro Biopharma (STRO) to Underperform
Mar 14, 2025 04:11AM Wedbush Downgrades Sutro Biopharma (STRO) to Neutral
Mar 14, 2025 03:07AM Citizens JMP Downgrades Sutro Biopharma (STRO) to Market Perform
Mar 13, 2025 04:05PM Sutro Biopharma Inc. (STRO) Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline
Feb 3, 2025 04:43AM JMP Securities Biotechnology Overview
Nov 13, 2024 06:06PM Sutro Biopharma, Inc. (STRO) Tops Q3 EPS by 14c
Oct 11, 2024 07:55AM Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)
Oct 11, 2024 07:01AM BofA Securities Reiterates Buy Rating on Sutro Biopharma (STRO)
Oct 11, 2024 06:36AM H.C. Wainwright Reiterates Buy Rating on Sutro Biopharma (STRO)
Sep 17, 2024 05:54AM Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)
Sep 16, 2024 09:11AM TD Cowen Reiterates Buy Rating on Sutro Biopharma (STRO)
Aug 22, 2024 08:04AM Sutro Biopharma Inc. (STRO) Announces Initiation of REFRĪ±ME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer
Aug 16, 2024 07:06AM Sutro Biopharma (STRO) PT Lowered to $15 at Truist Securities
Aug 14, 2024 02:21PM TD Cowen Reiterates Buy Rating on Sutro Biopharma (STRO)
Aug 14, 2024 08:25AM Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)